Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't believe Anavex did not know/count drop outs when they planed the trial.
That's kind a lame explanation trying to portrait the company dumb.
An interview with Dr. Grimmer in Munich, Germany! Holy Moly!
Thanks.
Thant's a real good advancement for human kind and for Anavex.
Thanks!
Is this the same Gator I read 7 years ago? lol
It's been long way with many disappointments, hasn't it?
Somehow feel less riskier, strange.
GLTY
I’m with ya.
Dear Dr. Missling, We DO hope that you present all necessary data that people have questioned since CTAD as they fit to your claim this time.
50% of me think it may not happen before/on the event as things don't go as I hope most of the time.
Oh those messages were for the CEO? Lol Very poor reasoning.
Welcome on board, Dr. Oph
Nice! You are bringing the puzzle pieces I was looking for.
Thanks.
My guess is that what you expect to see and what Dr. Missling thinks are different.
I doubt that he, as a CEO of Bio company, doesn't know what you know.
I reread the article and it's very encouraging to see that Anavex & Biogen are put on the same stage among other big scientific advances in Nature's article "The science events to watch for in 2023". Thank you for posting, Ace11.
Welcome on board!
It's good to see a seemingly knowledgeable investor supports the company. : )
Thanks!
I shouldn't have put Ariana Pharma’s AI technology and Precision Medicine in a same post. I think there must be a gap between conventional statistic/calculation & 'Ariana Pharma’s AI technology to illustrate results' (from Forbes' article).
"The company leveraged Ariana Pharma’s AI technology to illustrate the promising results of its drug."
Does this mean that Anavex uses a brand new way of presenting their successful results rather than conventional statistics & calculations?
And that is why Dr. Missling repeated saying that we met both end points?
'Precision medicine' was a hot issue on this board a couple years ago.
I vaguely remember that Dr. Missling got involved in a committee(?) at FDA for that matter. We might need to dig more into Ariana's roll in our trial.
…..which Missling and company confirmed lately that they’d announce it before the end of year.
Don’t you remember last year the exact same thing happened?
A milestone ( I don’t remember which now) was supposed to be done by EOY. CM kept on saying he would several times even till near the EOY. And he blew it. That was terrible.
That's deep, very deep. Thanks.
Can the company not announce when they file a NDA, you think?
To me they should/would.
That's what all longs hope.
I'm worried now because I got PTSD from all the PR's by the company past years including last two CC.
3.15 million volume with more than 70% ‘buy’ at the weekend.
Haven't seen this much 'buy'.
#1. How? That is THE question.
The rest will follow when we pass #1.
That's the best way of de-risking. lol
When I take Dr Missling's words we had de-risked on Dec 1.
How to prove it- seems to be uncertain at this point but I'm sure Anavex team has a plan.
I agree that we don't know.
And Anavex team know better about the trial than our MB team.
CM said we met both end points- somehow.
My question is: Are we more or less risky since Dec 1?
Some feel that we de-risked more; others don't agree.
What do you think?
You too twisted the article.
He never hinted that “….the data may not be what the company is claiming...”.
He simply said skip Avxl for general risks involved with investing biotech companies.
You just showed up here wrong timing, lol, as many longs got sensitive for recent stock actions and irritated by a poster right before you. I knew you were innocent but the question was kinda ignorant. Lol
Good luck
You acted on ignatiusrielly35's suggestion very fast. Good move, buddy.
The last sentence- If that’s what you think about the value of Anavex, what are all the fusses you have shown past 7 days for? We were $1B MC a month ago and you think that’s reasonable? Now your true color is exposed. Lol
except it's not one of science conferences.
on the other hand, maybe better than CTAD where BIIB was the star of the show?
"I want you to remember the numbers of the doses here for a reason... placebo declined... the medium dose stopped the decline... but the high dose group was above baseline... so patients coming into the trial came out with better cognitive features. And the reason I want you to remember these doses is that it's exactly the same doses as in the upcoming Alzheimer's study. Placebo, thirty, fifty."
Above is a quotation from a post after Guggenheim presentation on 11/14.
And there were more posts of CM's excitements by saying "Not only but also...........", "Remeber........ remember.........."
Those really made our expectation up. Remember so many here got excited and said the best presentation, etc etc.
Was CM acting/faking and pumping? He did well on that day but not at CTAD.
He really fu..d up. My first time bashing CEO.
The intent of my posting was to prompt alternative thinking. Blarcamesine will be bigger and more effective than currently being presumed by so many.
Thank you for clarifying your post earlier today. I thought that you were saying our p3 trial results were not impressive therefore we go and assist Aricept to help Alzheimer patients. ha!
Yea.... more of waiting. Anavex will make all in the pipelines through one by one!
48% drop since 11/14 high @ $14.6. SP acts like the trial did not meet the both end points. It's painful to watch.
Bored and nothing to do?
Go out and breath the air.
I understand your defense but what’s the base of sales you talking about? If you can’t show it your post is just a dribble. Are you the who pushed a special approval of Anavex in Australia a couple years ago?
Is this a joke? lol.
I don't believe that Missling would hide bad outcomes that a MB poster can calculate out. A nice try though.
She mentions only Anavex : ) in her article-
How Digital Innovation Is Changing Life Sciences and the Way We Treat Dementia
She is a digital marketing expert and a CEO; she actually is promoting Anavex in the article. Nice!
It happens with AVXL always? Tell me when that happened prior to this ctad. Don’t say never ??
A positive opinion on tweet for some comfort:
Yes I need some comfort. Sorry if it is duplicated.
$AVXL @AnavexLifeSci @Merck @Roche @pfizer_news @GSKUS
— zeus (@zeusPharma) December 5, 2022
My take on Anavex2-73. pic.twitter.com/128jCy3V7w
Thank you for the information
Thank you for sharing. Really appreciated.